SCHEMBL6769423

SCHEMBL6769423

CS(=O)(=O)NC(=N)NCCC[C@H](NC(=O)OCc1ccccc1)C(=O)N1CCCC1

nearest known ligand 0.60

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TGM2 P21980 20/20 0.60
F13A1 P00488 2/20 0.53
TGM1 P22735 2/20 0.53
TGM6 O95932 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6763781 0.87 SIRT2 (0.56) TGM2
SCHEMBL6766563 0.81 ITGB3 (0.65) TGM2F13A1TGM1TGM6
SCHEMBL13598866 0.81 ITGB3 (0.65) TGM2F13A1TGM1TGM6
SCHEMBL6445875 0.81 TGM2 (0.58) TGM2F13A1TGM1TGM6
SCHEMBL5712251 0.80 ITGB3 (0.70) TGM2F13A1TGM1TGM6
SCHEMBL7294359 0.79 DPP4 (0.58) TGM2F13A1TGM1TGM6
SCHEMBL17007552 0.78 TGM2 (0.83) TGM2F13A1TGM1TGM6
Hydrochloric Acid SCHEMBL6767096 0.78 DPP4 (0.58) TGM2F13A1TGM1TGM6
SCHEMBL30054191 0.77 CTSL (0.56) TGM2F13A1TGM1
SCHEMBL6763753 0.77 F2 (0.35) TGM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716843-B2 INHIBITOR OF DIPEPTIDYL-PEPTIDASE IV LES LABORATOIRES SERVIER (FR) 2004-04-06 US disclosed
US-20030087950-A1 New alpha-amino acid sulphonyl compounds LES LABORATOIRES SERVIER (FR) 2003-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030087950-A1 New alpha-amino acid sulphonyl compounds DNPEP, DPP4, DPP7 TGM2 550/4885F13A1 1939/4885TGM1 279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.